News and Knowledge

Medicines Access

Expediting Access to Rare Disease Therapies in Europe

Globally there are approximately 7,000 known rare diseases. About 4,000 – 5,000 of those have no available therapies. Consequently, there are many patients with a rare disease who are waiting…
Medicines Access

Providing Access to Unlicensed Medicines

What’s driving demand for unlicensed medicines in non-launch or non-com-mercialised markets? And what are the challenges for the pharmaceutical manufacturer of not actively engaging in providing access? Irrespective of the manufacturers stance,…
Thought leadership

How to navigate the challenges of a changing Chinese market

Kay-Christian Karstadt, COO and Head of Global Expansion Rapid economic and demographic changes are causing a boom in the Chinese market for pharmaceuticals. This offers opportunities for pharma companies, but…
Commercial products
Commercialize and partner successfully in Europe and the Middle East
Clinical Trial Services
Race the hurdles of global clinical trials
Medicines Access
What life science companies need to know about pre-approval access

Press Releases

Featured

New Chief Medical Officer joins Inceptua

LUXEMBOURG – 10 October 2018 Inceptua Group today announces that Maria Eklind-Cervenka joins as new Chief Medical Officer (CMO). “With Maria joining we are increasing our Medical Leadership, continuing to…
Press release

Strong industry profiles join Inceptua

Key appointments strengthen full lifecycle support for pharma LUXEMBOURG – 5 September 2018 – Inceptua Group (previously Multipharma) today announces the strengthening of its Commercial, Strategy, and Supply Chain teams…
Press release

Creation of Inceptua Clinical Trial Services marks new era for the company

LUXEMBOURG – 23 APRIL 2018 – Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of…